Objectives: Recent observations demonstrated the expression of the insulin receptor (InsR) and its functional interaction with the transient receptor potential vanilloid type 1 receptor (TRPV1) in sensory ganglion neurons. Because sensory nerves are implicated in pancreatic inflammatory processes, we studied the colocalization of the InsR with TRPV1 and proinflammatory neuropeptides in spinal and vagal pancreatic afferent neurons.
T he sensory innervation of abdominal organs subserve many important physiological and pathophysiological functions including the maintenance of homeostasis, reflex regulation of visceral processes, and sensation of visceral discomfort and pain. Apart from these classical sensory functions, peptidergic sensory nerves possess sensory efferent or local regulatory functions through the release of neuropeptides, such as substance P (SP) and calcitonin gene-related peptide (CGRP). [1] [2] [3] This particular population of somatic and visceral chemosensitive sensory ganglion neurons is capsaicin sensitive 2, 4, 5 and expresses the nonselective cation channel transient receptor potential vanilloid type 1 receptor (TRPV1), a member of the TRP receptor superfamily. 6, 7 Experiments using the capsaicin-induced selective chemodenervation paradigm and TRPV1 knockout mice have revealed that chemosensitive primary sensory neurons are essential in the detection of painful heat and chemical stimuli, as well as in the development of local vascular and inflammatory reactions, such as neurogenic inflammation. [2] [3] [4] 8 In addition, mediating neurogenic inflammatory responses, chemosensitive afferent nerves significantly contribute to essentially nonneurogenic inflammatory processes including the development of diseases of both the endocrine and the exocrine pancreata. [9] [10] [11] [12] [13] For example, SP has been shown to significantly contribute to the initiation of the inflammatory process in acute pancreatitis. 11, 14, 15 Moreover, peptidergic primary sensory neurons have been considered as a common final pathway for inflammation in various models of experimental pancreatitis. 9, 11, 16 Immunohistochemical studies have also revealed the coexpression of SP and CGRP with TRPV1 in sensory nerves serving the islets of Langerhans. 13, 17 It has been suggested that dysfunction of capsaicin-sensitive peptidergic nerves, in particular those that contain SP, may significantly contribute to the development of impaired islet function resulting in type 1 diabetes. 12, 13, 17 Recently, the coexpression of TRPV1 and the insulin receptor (InsR) has also been demonstrated in dorsal root ganglion (DRG) neurons with unidentified target innervation. 10, 18 Importantly, evidence for functional interactions between TRPV1 and the InsR has also been presented in cultured sensory ganglion neurons. 10, 19 In addition to insulin, insulinlike growth factor 1 (IGF-I) also activates TRPV1 in cultured rat and mouse DRG neurons. All the insulin-and IGF-I-responsive cells were also capsaicin sensitive in both species. 10, 18, 19 Similarly, both insulin and IGF-I produced acute sensitization of the capsaicin-induced Ca transient in cultured trigeminal ganglion neurons. 20 Importantly, it has been demonstrated that insulin directly activates mouse pancreatic vagal afferents and induces depolarization and increases in [Ca 2+ ] i . It has been suggested that this response is mediated by the activation of insulin receptor substrate 2 (IRS2), PI3K, and L-type and N-type Ca 2+ channels. Furthermore, this report also showed that InsR and IRS2 are expressed in these neurons. 21 More recently, TRPV1-expressing sensory nerves have been implicated in other pancreatic pathologies, such as the initiation and progression of cancer in a genetic model of ductal adenocarcinoma of the pancreas. 22 Considering the multiple roles of sensory nerves in pathological processes of the pancreas, characterization of neurochemically diverse populations of pancreatic sensory ganglion neurons is of critical importance as regards the further understanding of the role of sensory nerves in pancreatic pathology. Therefore, the aim of the present study was to reveal, by using retrograde neuronal labeling and quantitative immunohistochemistry, the neurochemical phenotypes of identified rat spinal and vagal pancreatic afferent neurons with particular emphasis on the colocalization of the TRPV1 with the InsR, SP, and CGRP.
MATERIALS AND METHODS
All experiments were approved by the Ethics Committee for Animal Care at the University of Szeged and were carried out in full accordance with the Directive 2010/63/EU of the European Parliament and of the Council on the Protection of Animals Used for Scientific Purposes and the guidelines of the Committee for Research. All efforts were made to minimize animal suffering. The number of experimental animals was kept as low as possible.
Retrograde Labeling of Pancreatic Afferent Neurons With Biotin-Conjugated Wheat Germ Agglutinin
Adult male Wistar rats (n = 7) weighing 300 to 350 g were used in this study. The rats were anesthetized with chloral hydrate (400 mg/kg, intraperitoneally; Reanal, Budapest, Hungary). The abdominal cavity was exposed by a midline incision, and the pancreas was carefully exposed. To identify pancreatic spinal and vagal primary afferent neurons, biotin-conjugated wheat germ agglutinin (bWGA) 23 (1% in distilled water, 4 Â 2 μL; SigmaAldrich, Gillingham, United Kingdom) was injected into the pancreas with a Hamilton microsyringe. Thereafter, the exposed area was thoroughly rinsed with saline, and the abdominal wall was closed in layers. After recovery from anaesthesia, the rats were returned to the animal house. Three days later, the animals were reanesthetized and perfused transcardially with physiological saline followed by a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The Th9-L1 spinal sensory ganglia, which contain the majority of parent cell bodies of pancreatic spinal ganglion neurons, 24, 25 and the nodose ganglia (NGs) were removed, postfixed in the same fixative for 2 hours and then stored in 0.1 M phosphate buffer (pH 7.4) containing 30% sucrose. Serial frozen sections, 15 μm in thickness, were cut from the DRGs and the NGs and processed for immunohistochemistry.
Immunohistochemistry
Sections were rinsed in phosphate-buffered saline (PBS) for 2 Â 10 minutes, incubated in PBS containing 1% donkey serum and 0.1% Triton X-100 for 30 minutes, and processed for staining with the indirect immunofluorescence technique using the following antibodies: rabbit anti-InsRα subunit antibody (1:500; Santa Cruz Biotechnologies, Dallas, Tex), guinea pig anti-TRPV1 antibody (1:1500; Neuromics, Edina, Minn), mouse anti-CGRP antibody (1:1500; Abcam, Cambridge, United Kingdom), and guinea pig anti-SP antibody (1:1500; Abcam). Donkey anti-rabbit immunoglobulin G (IgG) labeled with DL488 (1:500), donkey anti-guinea pig IgG labeled with Cy3 (1:500), and donkey anti-mouse IgG labeled with Cy3 (1:500) were used as secondary antibodies (all from Jackson ImmunoResearch Laboratories, West Grove, Pa). Biotinconjugated wheat germ agglutinin lectin was detected by using an extravidine-AMCA conjugate (Jackson ImmunoResearch Laboratories). All antibodies were diluted in PBS containing Triton X100 (0.3%). Sections were incubated in the presence of the primary antibodies overnight followed by a 2-hour incubation with the secondary antibodies. Specimens were covered with Prolong Gold antifade mounting medium (Invitrogen, Carlsbad, Calif ). 
Analysis of Identified Pancreatic Afferent Neurons

RESULTS
Retrograde Labeling of Pancreatic Afferent
Neurons Using bWGA Injection of bWGA into the pancreas resulted in the labeling of a great number of neurons in the Th9-L1 and NGs on both sides. Quantitative analysis revealed that 263 and 167 neurons were retrogradely labeled with bWGA in the spinal ganglia and NGs, respectively. The mean cross-sectional area of the labeled DRG and NG neurons amounted to 510.2 (SD, 69.4) μm 2 and 558.5 (SD, 44.9) μm 2 , respectively. Photomicrographs in Figures 1 and 2 illustrate examples of retrogradely labeled pancreatic spinal and vagal sensory ganglion neurons exhibiting InsR and TRPV1 immunopositivity, InsR and CGRP immunopositivity, and InsR and SP immunopositivity.
Colocalization of the InsR and the TRPV1 Receptor in Identified Pancreatic Afferent Neurons
In the DRGs, 68.2% (SD, 4.8%) and 48.3% (SD, 2.6%) of the labeled neurons showed TRPV1 and InsR immunopositivity, respectively. Of the retrogradely labeled DRG neurons, 23.2% (SD, 2.2%) displayed InsR and TRPV1 colocalization. Of the retrogradely labeled InsR-positive DRG neurons, 50.1% (SD, 3.0%) were immunoreactive for the TRPV1, and 34.0% (SD, 1.96%) of the retrogradely labeled TRPV1-positive DRG neurons were immunoreactive for the InsR (Fig. 3A) .
In the NGs, 64.0% (SD, 3.9%) and 49.1% (SD, 2.5%) of the retrogradely labeled neurons showed TRPV1 and InsR immunopositivity, respectively. In the NGs, 35.3% (SD, 1.7%) of the retrogradely labeled neurons displayed InsR and TRPV1 receptor colocalization. Of the retrogradely labeled InsR-positive neurons, 71.0% (SD, 5.0%) displayed TRPV1 immunoreactivity, and conversely, 55.4% (SD, 2.0%) of the retrogradely labeled TRPV1 receptor-immunoreactive neurons were immunopositive for the InsR (Fig. 3B) .
Colocalization of InsR, CGRP, and SP Immunoreactivities in Identified Pancreatic Afferent Neurons
In the Th9-L1 DRGs and in the NGs, 33.2% (SD, 3.7%) and 40.0% (SD, 2.1%) of the retrogradely labeled neurons, respectively, showed SP immunoreactivity. In the DRGs and the NGs, the colocalization of InsR and SP immunoreactivities was demonstrated in 14.4% (SD, 1.2%) and 24.2% (SD, 1.0%) of retrogradely labeled neurons, respectively.
In the DRGs, 28.4% (SD, 1.3%) of the retrogradely labeled InsR-positive neurons displayed SP immunoreactivity, and conversely, 42.0% (SD, 4.8%) of the retrogradely labeled SP-immunopositive neurons were immunoreactive for the InsR. In the NGs 30.0% (SD, 1.9%) of the retrogradely labeled InsRpositive neurons displayed SP immunoreactivity, and 60.2% (SD, 4.2%) of the retrogradely labeled SP-immunopositive neurons were immunoreactive for the InsR (Figs. 3C, D) .
Calcitonin gene-related peptide immunoreactivity was demonstrated in 54.3% (SD, 4.4%) and 25.1% (SD, 2.9%) of the labeled neurons in the DRGs and the NGs, respectively. The difference between the 2 populations was significant (0.008). Of the retrogradely labeled DRG and NG neurons, 28.4% (SD, 2.7%) and 8.0% (SD, 0.9%) of the InsR-immunoreactive neurons also showed CGRP immunoreactivity. This difference was also significant (0.030).
Of the retrogradely labeled InsR-positive DRG neurons, 58.3% (SD, 5.3%) displayed CGRP immunoreactivity, and conversely, 52.1% (SD, 4.4%) of the retrogradely labeled CGRPimmunopositive neurons were immunoreactive for the InsR. In the NGs, 17.4% (SD, 3.6%) of the retrogradely labeled InsR-positive neurons displayed CGRP immunoreactivity, and conversely, 32.0% (SD, 2.5%) of the retrogradely labeled CGRP-immunopositive neurons were immunoreactive for the InsR (Figs. 3E, F) .
DISCUSSION
Previous studies have revealed that a significant proportion of sensory nerves innervating the pancreas are capsaicin sensitive. 26, 27 Our findings confirmed these observations by showing that up to 70% of retrogradely labeled small to medium pancreatic primary afferent neurons in both the thoracolumbar DRGs and the NGs showed TRPV1 immunoreactivity. Hence, the majority of pancreatic primary sensory neurons express the TRPV1. These neurons are implicated in the mediation of inflammatory pain and in the neurogenic regulation of inflammatory processes.
Previous morphological and functional studies demonstrated the colocalization of TRPV1 and InsR in DRG neurons of unknown target innervation. 10, 18 In the present experiments, we detected for the first time the presence of InsR in identified pancreatic afferent neurons. Insulin receptor immunoreactivity was demonstrated in similar proportions of the retrogradely labeled DRG and NG neurons. Our data also demonstrated the colocalization of the TRPV1 and the InsR in identified pancreatic primary afferent neurons. In the DRGs and the NGs, 23% and 35% of the bWGA-labeled neurons showed both InsR and TRPV1 immunopositivity.
Substance P and CGRP are characteristic markers of peptidergic primary afferent neurons. [28] [29] [30] Earlier histological studies have shown a significant colocalization of SP, CGRP, and the TRPV1 in sensory nerves that innervate both the exocrine and the endocrine pancreata. 13 In the present study, analysis of the colocalization of CGRP with the InsR has revealed a significantly higher proportion of DRG neurons (~28%) that colocalized CGRP and the InsR as compared with the NGs (~8%). This finding supports the notion that spinal afferents expressing the nociceptive peptide CGRP may play a significant role in the mediation of pancreatic pain and inflammation. 13, 14 Our quantitative data have also revealed a rather high proportion of pancreatic SP-immunoreactive primary sensory neurons both in the DRGs (~33%) and the NGs (~40%). Furthermore, in the retrogradely labeled neurons, the coexpression rate of SP and the InsR is high in both the nodose and the spinal ganglia.
The involvement of chemosensitive peptidergic afferent nerves that express the TRPV1 in inflammatory processes of the pancreas is well established. 9, 11, 15, 16, 31 The present findings, by showing the colocalization of the TRPV1 with SP in pancreatic afferent neurons, provide further support for this notion. The activation of TRPV1 results in the release of the proinflammatory neuropeptides, such as SP and CGRP from the sensory nerves, and contributes to the pathomechanism of acute pancreatitis. 11, 16 Furthermore, in recent years, several reports have indicated the role of SP in pathological conditions of the endocrine pancreas; it has been revealed that SP mediates insulitis, an inflammatory process affecting the islets of Langerhans, which may lead to the development of type 1 diabetes. 12, 17 The most important finding of the present study is the demonstration of InsRs in pancreatic vagal and spinal sensory ganglion neurons and its colocalization with the TRPV1, SP, and CGRP. Insulin receptor has been shown to be functional in primary afferent neurons by modulating the capsaicin-induced activation of the TRPV1. 10, 19 Because activation of the TRPV1 is associated with the release of proinflammatory peptides, such as SP, from pancreatic afferent nerves, 9, 11, 16 we suggest that InsRs, by modulating the activation of the TRPV1, 10, 12, 19, 20 may play a role in the mediation of pancreatic pain and in the pathomechanism of pancreatic inflammatory processes.
Based on previous observations and the present study, it is assumed that activation of neural TRPV1 by insulin may contribute to the formation of a vicious cycle resulting in an exaggeration of pancreatic inflammatory processes. Hence, activation of the TRPV1 is accompanied by the release of the proinflammatory neuropeptides SP and CGRP, which produce additional inflammatory changes, such as increase in vascular permeability and vasodilatation, 32 as well as leukocyte activation. 9, [33] [34] [35] [36] [37] [38] Tissue inflammation, in turn, results in the up-regulation of the neuronal synthesis of SP and CGRP, 33, 39 which can be then released following the activation of neural TRPV1 by inflammatory mediators, increased tissue acidity (for a review, see Nagy et al 40 ), and, importantly, by insulin. 10, 19 This suggestion is supported by the findings showing that in the rat the pancreatic parenchyma, including the islets of Langerhans, is exposed to very high levels of insulin during the secretory process of the hormone. 41 Insulin, by reaching sensory nerves, which have been demonstrated in the immediate surroundings of the islet apparatus 12, 13, 17, 21 and also in the exocrine pancreas, 
